Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy

【24h】

机译：有不同的阈值的证据基因与临床精密药吗?信息化框架应用的价值抗血小板药物治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

页面导航

摘要

Background: The threshold of sufficient evidence for adoption of clinically- and genomically-guided precision medicine (PM) has been unclear.

机译：背景:足够的证据的阈值采用临床和genomically-guided精密医学(PM)是不清楚。

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2019年第9期|988-994|共7页
作者
Guzauskas Gregory F.; Basu Anirban; Carlson Josh J.Veenstra David L.;
展开▼
作者单位

Univ Washington, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Dept Pharm, H375 HSB,Box 357630;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词
Genomics; Antiplatelet Agents; Precision MedicineFrameworks;

机译：MedicineFrameworks;